These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 24374162)

  • 1. The molecular and cellular pathology of α₁-antitrypsin deficiency.
    Gooptu B; Dickens JA; Lomas DA
    Trends Mol Med; 2014 Feb; 20(2):116-27. PubMed ID: 24374162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein Misfolding and Aggregation: The Relatedness between Parkinson's Disease and Hepatic Endoplasmic Reticulum Storage Disorders.
    Padilla-Godínez FJ; Ramos-Acevedo R; Martínez-Becerril HA; Bernal-Conde LD; Garrido-Figueroa JF; Hiriart M; Hernández-López A; Argüero-Sánchez R; Callea F; Guerra-Crespo M
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular pathogenesis of alpha-1-antitrypsin deficiency.
    Duvoix A; Roussel BD; Lomas DA
    Rev Mal Respir; 2014 Dec; 31(10):992-1002. PubMed ID: 25442121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. hiPSC hepatocyte model demonstrates the role of unfolded protein response and inflammatory networks in α
    Segeritz CP; Rashid ST; de Brito MC; Serra MP; Ordonez A; Morell CM; Kaserman JE; Madrigal P; Hannan NRF; Gatto L; Tan L; Wilson AA; Lilley K; Marciniak SJ; Gooptu B; Lomas DA; Vallier L
    J Hepatol; 2018 Oct; 69(4):851-860. PubMed ID: 29879455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deficiency Mutations of Alpha-1 Antitrypsin. Effects on Folding, Function, and Polymerization.
    Haq I; Irving JA; Saleh AD; Dron L; Regan-Mochrie GL; Motamedi-Shad N; Hurst JR; Gooptu B; Lomas DA
    Am J Respir Cell Mol Biol; 2016 Jan; 54(1):71-80. PubMed ID: 26091018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Mechanism of Mitochondrial Injury in Alpha-1 Antitrypsin Deficiency Mediated Liver Disease.
    Khodayari N; Wang RL; Oshins R; Lu Y; Millett M; Aranyos AM; Mostofizadeh S; Scindia Y; Flagg TO; Brantly M
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practical genetics: alpha-1-antitrypsin deficiency and the serpinopathies.
    Crowther DC; Belorgey D; Miranda E; Kinghorn KJ; Sharp LK; Lomas DA
    Eur J Hum Genet; 2004 Mar; 12(3):167-72. PubMed ID: 14694355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-1-antitrypsin deficiency: Genetic variations, clinical manifestations and therapeutic interventions.
    Hazari YM; Bashir A; Habib M; Bashir S; Habib H; Qasim MA; Shah NN; Haq E; Teckman J; Fazili KM
    Mutat Res Rev Mutat Res; 2017 Jul; 773():14-25. PubMed ID: 28927525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic targeting of misfolding and conformational change in α1-antitrypsin deficiency.
    Nyon MP; Gooptu B
    Future Med Chem; 2014 Jun; 6(9):1047-65. PubMed ID: 25068987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New Concepts in Alpha-1 Antitrypsin Deficiency Disease Mechanisms.
    Marciniak SJ; Ordóñez A; Dickens JA; Chambers JE; Patel V; Dominicus CS; Malzer E
    Ann Am Thorac Soc; 2016 Aug; 13 Suppl 4():S289-96. PubMed ID: 27564663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. α(1)-antitrypsin deficiency and inflammation.
    Ekeowa UI; Marciniak SJ; Lomas DA
    Expert Rev Clin Immunol; 2011 Mar; 7(2):243-52. PubMed ID: 21426261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting intracellular degradation pathways for treatment of liver disease caused by α1-antitrypsin deficiency.
    Wang Y; Perlmutter DH
    Pediatr Res; 2014 Jan; 75(1-2):133-9. PubMed ID: 24226634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular basis of α1-antitrypsin deficiency revealed by the structure of a domain-swapped trimer.
    Yamasaki M; Sendall TJ; Pearce MC; Whisstock JC; Huntington JA
    EMBO Rep; 2011 Sep; 12(10):1011-7. PubMed ID: 21909074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What we owe to alpha(1)-antitrypsin and to Carl-Bertil Laurell.
    Carrell RW
    COPD; 2004 Apr; 1(1):71-84. PubMed ID: 16997740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel treatment strategies for liver disease due to α1-antitrypsin deficiency.
    Maurice N; Perlmutter DH
    Clin Transl Sci; 2012 Jun; 5(3):289-94. PubMed ID: 22686209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of endoplasmic reticulum-specific stress responses associated with the conformational disease Z alpha 1-antitrypsin deficiency.
    Lawless MW; Greene CM; Mulgrew A; Taggart CC; O'Neill SJ; McElvaney NG
    J Immunol; 2004 May; 172(9):5722-6. PubMed ID: 15100318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha(1)-antitrypsin deficiency, liver disease and emphysema.
    Parfrey H; Mahadeva R; Lomas DA
    Int J Biochem Cell Biol; 2003 Jul; 35(7):1009-14. PubMed ID: 12672469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heteropolymerization of α-1-antitrypsin mutants in cell models mimicking heterozygosity.
    Laffranchi M; Berardelli R; Ronzoni R; Lomas DA; Fra A
    Hum Mol Genet; 2018 May; 27(10):1785-1793. PubMed ID: 29538751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An autophagy-enhancing drug promotes degradation of mutant alpha1-antitrypsin Z and reduces hepatic fibrosis.
    Hidvegi T; Ewing M; Hale P; Dippold C; Beckett C; Kemp C; Maurice N; Mukherjee A; Goldbach C; Watkins S; Michalopoulos G; Perlmutter DH
    Science; 2010 Jul; 329(5988):229-32. PubMed ID: 20522742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-1-antitrypsin deficiency: current concepts.
    Mulgrew AT; Taggart CC; McElvaney NG
    Lung; 2007; 185(4):191-201. PubMed ID: 17562108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.